364 27. Smith CL (1998) Cultures from chick periperal ganglia. In: Banker G, Goslin K (eds) Culturing nerve cells. MIT Press, Cambridge, pp 261–287 28. Axelrod D, Burghardt TP, Thompson NL (1984) Total internal reflection fluorescence. Annu Rev Biophys Bioeng 13:247–268. doi:10.1146/annurev.bb.13.060184.001335 29. Einstein A (1956) Investigations on the theory of the Brownian movement. Dover, New York 30. CAS (2008) SciFinder scholar. http://www.cas.org/SCIFINDER/ SCHOLAR/. Accessed 16 Jan 2008 31. Rani SA, Pitts B, Stewart PS (2005) Rapid diffusion of fluorescent tracers into Staphylococcus epidermidis biofilms visualized by time lapse microscopy. Antimicrob Agents Chemother 49:728– 732. doi:10.1128/AAC.49.2.728–732.2005 32. Mohrman DE (1988) Adenosine handling in interstitia of cre- master muscle studied by bioassay. Am J Physiol 254:H369–H376 33. Ming GL, Song HJ, Berninger B et al (1997) cAMP-dependent growth cone guidance by netrin-1. Neuron 19:1225–1235. doi:10.1016/S0896–6273(00)80414–6 34. Gundersen RW, Barrett JN (1979) Neuronal chemotaxis: chick dorsal-root axons turn toward high concentrations of nerve growth factor. Science 206:1079–1080. doi:10.1126/science.493992 35. Gundersen RW, Barrett JN (1980) Characterization of the turning response of dorsal root neurites toward nerve growth factor. J Cell Biol 87:546–554. doi:10.1083/jcb.87.3.546 36. Goodhill GJ (1997) Diffusion in axon guidance. Eur J Neurosci 9:1414–1421. doi:10.1111/j.1460–9568.1997.tb01496.x 37. Klotz KN (2000) Adenosine receptors and their ligands. Naunyn Schmiedebergs Arch Pharmacol 362:382–391. doi:10.1007/ s002100000315 38. Dunwiddie TV, Masino SA (2001) The role and regulation of adenosine in the central nervous system. Annu Rev Neurosci 24:31–55. doi:10.1146/annurev.neuro.24.1.31 39. Ongini E, Dionisotti S, Gessi S et al (1999) Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 359:7–10. doi:10.1007/PL00005326 40. Jarvis MF, Schulz R, Hutchison AJ et al (1989) [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain. J Pharmacol Exp Ther 251:888–893 41. Rothermel JD, Parker Botelho LH (1988) A mechanistic and kinetic analysis of the interactions of the diastereoisomers of adenosine 3′,5′-(cyclic)phosphorothioate with purified cyclic AMP-dependent protein kinase. Biochem J 251:757–762 42. Kopperud R, Krakstad C, Selheim F et al (2003) cAMP effector mechanisms. Novel twists for an ‘old’ signaling system. FEBS Lett 546:121–126. doi:10.1016/S0014–5793(03)00563–5 43. Kase H, Iwahashi K, Nakanishi S et al (1987) K-252 compounds, novel and potent inhibitors of protein kinase C and cyclic Purinergic Signalling (2008) 4:357–364 nucleotide-dependent protein kinases. Biochem Biophys Res Commun 142:436–440. doi:10.1016/0006–291X(87)90293–2 44. Stein E, Zou Y, Poo MM et al (2001) Binding of DCC by netrin- 1 to mediate axon guidance independent of adenosine A2B receptor activation. Science 291:1976–1982. doi:10.1126/science. 1059391 45. International Chicken Genome Sequencing Consortium (2004) Sequence and comparative analysis of the chicken genome provide unique perspectives on vertebrate evolutio. Nature 432:695–716 46. Aguilar JS, Tan F, Durand I et al (1995) Isolation and characterization of an avian A1 adenosine receptor gene and a related cDNA clone. Biochem J 307(Pt 3):729–734 47. Durand ICH, Green RD (2001) Cloning of a chick A3 adenosine receptor: characterization of ligand binding and receptor-effector coupling of chick A1 and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 363:81–86. doi:10.1007/s00210 0000340 48. Worpenberg S, Burk O, Klempnauer KH (1997) The chicken adenosine receptor 2B gen eis regulated by v-myb. Oncogene 15:213–221. doi:10.1038/sj.onc.1201179 49. Kaelin-Lang A, Lauterburg T, Burgunder JM (1998) Expression of denosine A2a receptor gene in a dorsal root and autonomic ganglia. Neurosci Lett 246:21–24. doi:10.1016/S0304–3940(98) 00216-X 50. Sawynok J (1998) Adenosine receptor activation and nocicep- tion. Eur J Pharmacol 347:1–11. doi:10.1016/S0014–2999(97) 01605–1 51. Yaar R, Jones MR, Chen JF et al (2005) Animal models for the study of adenosine receptor function. J Cell Physiol 202:9–20. doi:10.1002/jcp.20138 52. Zocchi C, Ongini E, Conti A et al (1996) The non-xanthine heterocyclic compound SCH 58261 is a new potent and selective A2a adenosine receptor antagonist. J Pharmacol Exp Ther 276: 398–404 53. Jacobson KA, Gao ZG (2006) Adenosine receptors as therapeutic targets. Nat Rev Drug Discov 5:247–264. doi:10.1038/nrd1983 54. Schulte G, Fredholm BB (2003) Signalling from adenosine receptors to mitogen-activated protein kinases. Cell Signal 15:813–827. doi:10.1016/S0898–6568(03)00058–5 55. Bos JL (2003) Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4:733–738. doi:10.1038/nrm1197 56. Christensen AE, Selheim F, de Rooij J et al (2003) cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278:35394– 35402. doi:10.1074/jbc.M302179200 57. Cronstein BM (2006) Adenosine receptors and wound healing, revised. Sci World J 6:984–991. doi:10.1100/tsw.2006.194